@article{f66de9076ada49349d4794b8b95a7d19,
title = "Mild chronic traumatic encephalopathy neuropathology in people with no known participation in contact sports or history of repetitive neurotrauma",
abstract = "It has been asserted that chronic traumatic encephalopathy (CTE) pathology is only present in former athletes and others who have been exposed to repetitive concussions, subconcussive blows, or both. We hypothesized that CTE pathology would be present in men who had no known history of repetitive neurotrauma. Comprehensive medical record reviews and health surveys completed by a family member were available for the 8 men in this case series, none of whom had known exposure to repetitive neurotrauma but 2 of whom had a history of traumatic brain injury (TBI). Postmortem tissue was immunostained for hyperphosphorylated tau (p-tau) to assess for CTE pathology, Braak stage, and aging-related p-tau. The neuropathologist was blind to age, personal history, and clinical history. Six of the 8 cases (75%) showed p-tau in neurons, astrocytes, and cell processes around small blood vessels in an irregular pattern at the depths of the cortical sulci. The changes were focal and limited in terms of overall extent, and some of the cases had a clearer pattern of pathology and some could be considered equivocal. Two of the 8 cases had a history of TBI and one of them showed CTE pathology. Five of the 6 cases with no known history of neurotrauma appeared to meet consensus criteria for CTE. This study adds to the emerging literature indicating that CTE pathology is present in people not known to have experienced multiple concussions or subconcussive blows to the head.",
keywords = "Brain injury, Chronic traumatic encephalopathy, Concussion, Sports",
author = "Iverson, {Grant L.} and Luoto, {Teemu M.} and Karhunen, {Pekka J.} and Castellani, {Rudolph J.}",
note = "Funding Information: From the Department of Physical Medicine and Rehabilitation, Harvard Medical School (GLI);Spaulding Rehabilitation Hospital, Spaulding Research Institute (GLI); MassGeneral Hospital for ChildrenTM Sports Concussion Program (GLI); Home Base, A Red Sox Foundation and Massachusetts General Hospital Program (GLI), Boston, Massachusetts; Department of Neurosurgery, Tampere University Hospital and Univer-sity of Tampere, Tampere, Finland (TML); Department of Forensic Med-icine, Faculty of Medicine and Life Sciences, University of Tampere (PJK); Fimlab Laboratories and Finnish Cardiovascular Research Center Tampere (PJK), Tampere, Finland; Department of Pathology, Anatomy and Laboratory Medicine (RJC); Department of Neuroscience, Rockefel-ler Neuroscience Institute (RJC); and West Virginia University School of Medicine (RJC), Morgantown, West Virginia Send correspondence to: Grant L. Iverson, PhD, Department of Physical Medicine and Rehabilitation, Center for Health and Rehabilitation Re-search, 79/96 Thirteenth Street, Charlestown Navy Yard, Charlestown, MA 02129; E-mail: giverson@mgh.harvard.edu Dr Grant Iverson has been reimbursed by the government, professional sci-entific bodies, and commercial organizations for discussing or presenting research relating to MTBI and sport-related concussion at meetings, sci-entific conferences, and symposiums. He has a clinical practice in foren-sic neuropsychology involving individuals who have sustained mild TBIs (including athletes). He has received honorariums for serving on re-search panels that provide scientific peer review of programs. He is a co-investigator, collaborator, or consultant on grants relating to mild TBI funded by the federal government and other organizations. He has re-ceived research support from test publishing companies in the past, in-cluding ImPACT Applications Systems, Psychological Assessment Resources, and CNS Vital Signs. He has received support from the Har-vard Integrated Program to Protect and Improve the Health of NFLPA Members. He serves as a scientific advisor for BioDirection, Inc. He acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation, Heniz Family Foundation, and ImPACT Applica-tions, Inc. Dr. Castellani has been reimbursed for travel for speaking at educational programs and has received fees for medicolegal consulting. He has received intramural research funding at Western Michigan Uni-versity School of Medicine, unrelated to this study. He is subcontracted to the NIH Neurobiobank at the University of Maryland and the Lieber Institute for Brain Development. The neuropathological examinations for this study were funded by Western Michigan University Homer Stryker MD School of Medicine. Publisher Copyright: {\textcopyright} 2019 American Association of Neuropathologists, Inc. All rights reserved.",
year = "2019",
month = jul,
day = "1",
doi = "10.1093/jnen/nlz045",
language = "English (US)",
volume = "78",
pages = "615--625",
journal = "Journal of neuropathology and experimental neurology",
issn = "0022-3069",
number = "7",
}